Black Rock Inc. Better Therapeutics, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.14 - $0.39 $54 - $152	-390 Reduced 0.44%	88,635 $17,000
Q3 2023 Nov 13, 2023	SELL	$0.34 - $1.23 $464 - $1,678	-1,365 Reduced 1.51%	89,025 $32,000
Q2 2023 Aug 11, 2023	BUY	$0.69 - $1.46 $6,363 - $13,465	9,223 Added 11.36%	90,390 $97,000
Q1 2023 May 12, 2023	BUY	$0.64 - $1.45 $510 - $1,157	798 Added 0.99%	81,167 $56,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $1.74 $1,809 - $2,862	1,645 Added 2.09%	80,369 $88,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $2.77 $4,247 - $7,689	2,776 Added 3.66%	78,724 $139,000
Q2 2022 Aug 12, 2022	BUY	$0.91 - $2.34 $69,112 - $177,718	75,948 New	75,948 $118,000

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.